THE APPOINTMENT OF JOE VACCA AS CSO AND PAUL SEKHRI AS OPERATING PARTNER STRENGTHENS HIGHLINE'S LEADERSHIP TEAM IN NEW YORK
Versant Ventures Broadens Geographic Footprint with Highline Therapeutics, Carlo Rizzuto appointed Venture Partner based in New York.
Versant Bites At The Apple
Highline Therapeutics Announces Alliance with Weill Cornell Medical College to Accelerate Biotech Company Formation.
VERSANT Walks Biotech "High Line" with a New Manhattan Incubator
This native new yorker returned home to stem the tide of a biotech brain drain